- Companies
- IVC Evidensia
IVC Evidensia Valuation, Funding & Investors
IVC Evidensia is valued at $14B as of February 2021.
About IVC Evidensia
IVC Evidensia is a European veterinary services provider operating more than 1,500 clinics and hospitals across 12 countries, employing approximately 22,000 people. The company offers general and specialist veterinary care and has expanded into telemedicine through its 2021 acquisition of PawSquad, a UK provider of online veterinary consultations via video and live text chat that serves both corporate partners, such as Direct Line Insurance, Blue Cross, and PDSA, and private pet owners.
Founded
2019
HQ
Website
Status
Privately held
Customer focus
B2C
Revenue model
Services
Valuation
$14B (Feb 2021)
Sectors
IVC Evidensia Valuation
IVC Evidensia is currently valued at $14B, based on its undisclosed-stage round in February 2021.
The $4.2B round included Silver Lake, EQT and Nestlé.
IVC Evidensia valuation by funding round
| Date | Stage | Valuation |
|---|---|---|
| Feb 2021 | Undisclosed stage | $14B |
IVC Evidensia Funding History
IVC Evidensia has raised a total of $4.2B across 1 funding round.
IVC Evidensia funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Feb 2021 | Undisclosed stage | Silver Lake; EQT; Nestlé | $4.2B | $14B | IVC Evidensia, Europe's leading veterinary services provider with over 1,500 clinics and hospitals and approximately 22,000 employees, expanded its partnership with EQT Private Equity, Nestlé, and new investor Silver Lake in February 2021. The transaction involved aggregated new investments totaling €3.5 billion, valuing the company at an enterprise value of approximately €12.3 billion. EQT made a substantial investment through its EQT IX fund, Silver Lake a new substantial minority stake, and Nestlé increased its minority position. The deal, announced on February 9, 2021, and expected to close by Q2 2021, aimed to accelerate growth, digitalization, and innovation in veterinary care. Silver Lake's involvement focused on technology opportunities to develop digital products. Financial advisors included Goldman Sachs, Jefferies, J.P. Morgan, and Numis. |
Who has invested in IVC Evidensia?
3 investors have backed IVC Evidensia across its funding rounds, including EQT, Silver Lake and Nestlé.
IVC Evidensia Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 1 | Participant | Feb 2021 | ||
This data is available for Pro users. Sign up to see all 3 IVC Evidensia investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAcquisitions by IVC Evidensia
IVC Evidensia has acquired 2 companies to date.
Last acquisition by IVC Evidensia was on October 28th 2021. IVC Evidensia acquired VetOne for undisclosed valuation.
Latest Acquisitions by IVC Evidensia
| Description | VetOne is a Paris-based network of veterinary hospitals operating throughout France. Its facilities provide comprehensive small animal care including preventive medicine, surgical interventions, diagnostic imaging, laboratory testing, and round-the-clock emergency services. The group maintains clinics in urban and suburban areas, emphasizing personalized treatment plans and owner education on pet nutrition and behavior. | PawSquad is a UK-based telemedicine service connecting pet owners to licensed veterinarians via video consultations and live text chat. Available 24/7 from any location, the platform delivers advice on health issues, preventive care, and behavioral concerns without requiring in-clinic visits. PawSquad's network of experienced vets addresses urgent queries promptly, helping prevent escalations and reduce unnecessary travel. The service operates from London, emphasizing convenience for busy owners. |
| HQ Country | ||
| HQ City | Paris | London |
| Deal Date | 28 Oct 2021 | 9 Mar 2021 |
| Valuation | undisclosed | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all IVC Evidensia acquisitions and their M&A valuation multiples. Start Free Trial | ||
IVC Evidensia Competitors
IVC Evidensia competitors include listed companies like Apollo Hospitals, Rede D'Or São Luiz, Encompass Health and IHH Healthcare, and private ones like Luz Saude and Metro Pacific Hospital Holdings.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $2.6B | $398M | $13B | 4.9x | ||
| Publicly listed | $11B | $1.3B | $16B | 1.6x | ||
| Publicly listed | $5.9B | $1.4B | $12B | 2.5x | ||
| Publicly listed | $6.3B | $1.5B | $17B | 3.0x | ||
| Private | - | $333M | $3.2B | - | ||
| Private | - | - | $1.6B | - |
IVC Evidensia Public Comps
IVC Evidensia is still privately-owned, but its public comps include Apollo Hospitals, Rede D'Or São Luiz, Encompass Health, IHH Healthcare, DaVita, Aier EYE Hospital Group, Universal Health Services, Max Healthcare Institute, Manipal Health and Bangkok Dusit Medical Services.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $2.6B | $398M | 5.3x | 4.9x | 34.9x | 32.1x | |||
| $11B | $1.3B | 1.7x | 1.6x | 14.3x | 8.4x | |||
| $5.9B | $1.4B | 2.7x | 2.5x | 11.2x | 11.7x | |||
| $6.3B | $1.5B | 3.3x | 3.0x | 13.8x | 13.6x | |||
| $14B | $2.6B | 1.9x | 1.9x | 9.9x | 9.1x | |||
| $3.3B | $955M | 3.4x | 3.3x | 11.9x | 11.6x | |||
| $17B | $2.7B | 0.9x | 0.9x | 5.8x | 6.1x | |||
| $858M | $232M | 12.6x | 10.2x | 46.5x | 36.8x | |||
This data is available for Pro users. Sign up to see all IVC Evidensia competitors and their valuation data. Start Free Trial | ||||||||
Common questions about IVC Evidensia
| When was IVC Evidensia founded? | IVC Evidensia was founded in 2019. |
| Where is IVC Evidensia headquartered? | IVC Evidensia is headquartered in Bristol, United Kingdom. |
| Is IVC Evidensia publicly listed? | No, IVC Evidensia is a private, VC-backed company. |
| What is IVC Evidensia's valuation? | IVC Evidensia was last valued at $14B in its undisclosed-stage round in February 2021. |
| How much funding has IVC Evidensia raised? | IVC Evidensia has raised $4.2B across 1 funding round. |
| What was IVC Evidensia's last funding round? | IVC Evidensia's last funding round was a $4.2B undisclosed-stage round in February 2021. |
| Who are IVC Evidensia's investors? | IVC Evidensia's investors include Silver Lake, EQT and Nestlé. |
| Which companies are comparable to IVC Evidensia? | Companies comparable to IVC Evidensia include Apollo Hospitals, Rede D'Or São Luiz, Encompass Health, IHH Healthcare, Luz Saude and Metro Pacific Hospital Holdings. |
| How many companies has IVC Evidensia acquired? | IVC Evidensia has acquired 2 companies, including VetOne and PawSquad. |
See companies similar to IVC Evidensia
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




